Brighton Jones LLC Has $1.07 Million Stake in Agilent Technologies, Inc. $A

Brighton Jones LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 89.5% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 9,068 shares of the medical research company’s stock after purchasing an additional 4,284 shares during the period. Brighton Jones LLC’s holdings in Agilent Technologies were worth $1,070,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in A. Vanguard Group Inc. boosted its stake in shares of Agilent Technologies by 0.7% in the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company’s stock worth $3,908,141,000 after buying an additional 240,965 shares during the last quarter. Pictet Asset Management Holding SA raised its holdings in shares of Agilent Technologies by 2.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company’s stock worth $624,888,000 after purchasing an additional 128,131 shares during the period. Generation Investment Management LLP raised its holdings in shares of Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after purchasing an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after acquiring an additional 604,124 shares during the period. Finally, Nordea Investment Management AB raised its holdings in Agilent Technologies by 16.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock valued at $383,143,000 after acquiring an additional 447,207 shares during the period.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on A. Wells Fargo & Company boosted their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a research report on Monday, September 15th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 8th. They set a “buy” rating and a $165.00 price target for the company. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Finally, Robert W. Baird upped their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Price Performance

Shares of NYSE A opened at $146.82 on Tuesday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a 50 day simple moving average of $130.95 and a two-hundred day simple moving average of $119.71. The company has a market capitalization of $41.62 billion, a price-to-earnings ratio of 34.47, a P/E/G ratio of 4.83 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm earned $1.32 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.